The protozoan parasite Cryptosporidium parvum causes waterborne diseases worldwide.
know if the sequence differences are PCR errors, mutations corresponding to DNA polymorphism, or if there are errors in the GenBank database.
Enzyme activity
LDH enzyme assays were performed in a temperature-controlled UV-Visible spectrophotometer (DU740, Beckman Instruments) using standard methods (Dando et al., 2001) . Reaction velocities were measured at 25  C for 1 min by following decrease or increase in absorbance at 340 nm due to oxidation of NADH or reduction of NAD + . The
CpLDH activity in the direction of reduction of pyruvate to lactate was measured in 50 mM sodium acetate buffer, pH 5.5, and activity in the direction of oxidation of lactate to pyruvate was measured in 50 mM Tris-HCl buffer, pH 9.1. A typical reaction mixture contained substrate (10 M -5 mM pyruvate or 50 μM -20 mM lactate) and cofactor (3 -150 μM NADH or 10 -600 μM NAD + ); enzyme reaction was initiated by adding 1 -5 μg of purified
CpLDH. The pH dependence of the CpLDH activity was determined using three buffers with overlapping pHs: 50 mM sodium acetate, pH 3.6 -6.0, 50 mM sodium phosphate, pH 5.6 -7.2 and 50 mM Tris-HCl, pH 6.6 -9.5. When APAD + /APADH was used as cofactor, reaction velocities were measured by following increase or decrease in absorbance at 363 nm due to reduction of APAD + or oxidation of APADH. The kinetic parameters (Michaelis constant K m , maximum velocity V max and turnover rate K cat ) for substrates and cofactors and the inhibitory constant K i value for gossypol were determined by non-linear regression using ANEMONA Excel templates (Hernandez and Ruiz, 1998) .
Crystallization and data collection
CpLDH was crystallized under several different conditions at 4C. As reported previously crystals of the apo enzyme suitable for data collection were grown from 16.5%
(v/v) PEG 2000, 0.1 M Tris-HCl (pH 7.0) and 0.08% n-octyl-β-D-glucopyranoside (Senkovich et al., 2005) . For crystallization of the ternary complexes, the concentrated protein was incubated with 1 mM substrate (pyruvate, lactate or oxamate) and 100 μM NADH, NAD + or APAD + for an hour on ice. Crystals of the ternary complexes were obtained at 4C using 1.45-1.65 M ammonium sulfate in 0.1 M sodium cacodylate (pH 6.75 to 7.25).
X-ray diffraction data were collected under cryogenic conditions (-180C) using a cryopreservative solution containing 25% glycerol in the reservoir solution. Intensity data were processed using Denzo and Scalepack (Otwinowski & Minor, 1997) . Crystals of apo CpLDH belong to space group P3 2 12 and contain four monomers (two dimers) in the asymmetric unit. Crystals of the ternary complexes belong to space group P3 2 21 and contain two monomers (one dimer) in the asymmetric unit.
Structure determination and refinement
The crystal structure of the ternary complex of CpLDH with pyruvate and APAD + was solved by molecular replacement using the CNS program package (Brünger et al., 1998) with data in the range 20 -4.5 Å for the rotation and translation searches. Calculation of a selfrotation function revealed a strong peak at kappa = 180º, indicating the presence of a noncrystallographic two-fold axis. Using a search model of CpLDH built from PfLDH (PDBID 1T2D), positions of the two monomers in the asymmetric unit were determined.
The correct enantiomorphic space group (P3 2 21) was determined from the values of correlation coefficient and R factor in the molecular replacement trials with the two enantiomorphic space groups. Refinement of the structure was performed initially by simulated annealing using CNS with the stereochemical parameter files defined by Engh and Huber (1991) . No sigma cutoff was applied to the data. Ten percent of the data was randomly selected and removed prior to refinement for analysis of the free R factor. The two subunits in the asymmetric unit were restrained by the non-crystallographic symmetry throughout the simulated annealing refinement. The molecular model was improved by cycles of manual fitting to 2Fo-Fc electron density maps using the program COOT (Emsley et al., 2010 ) alternating with refinement.
An Fo-Fc electron density map allowed placement of APAD + and pyruvate in each monomer. As the refinement progressed, water molecules were added by using the waterpicking routines in CNS and COOT. All water molecules were verified by inspection of the maps. In the later stages of refinement, noncrystallographic symmetry restraints were removed, and the restrained refinement option in REFMAC5 (Murshudov et al., 2011) was used.
The structures of the apo enzyme and the other three ternary complexes were solved by molecular replacement using the LDH dimer from the C. parvum LDH/APAD + /pyruvate structure as the search model. The refinement procedure was the same in each case as described above. 
Results
As reported previously purified recombinant CpLDH eluted as a tetramer as revealed by size exclusion chromatography (Senkovich et al., 2005) . On SDS PAGE analysis the purified protein migrated as a single band of approximately 33 kDa.
Enzyme activity
Using buffer solutions of overlapping pH, we determined pH optima for LDH reactions in both directions. The optimal pH for the reduction of pyruvate was 5.0 -5.5, but the optimal pH for the oxidation of lactate was 9.0 -9.5 ( Fig. 2A and B) . In Table 1 (Gomez et al., 1997) . In the case of CpLDH a small but significant negative cooperativity towards pyruvate was observed (Hill coefficient h= 0.69±0.00). However, in the case of NADH, the estimated cooperativity (Table   1) was not significant since the sum of least-squares after fitting the data to a Hill model was nearly identical to that observed after a pure Michaelis-Menten fit (data not shown). On the other hand, a negative cooperativity was observed when APAD + was used as a cofactor.
Gossypol and a number of its derivatives are known to inhibit LDH activity Conners et al., 2005) . As seen with other LDHs (Olgiati & Toscano, 1983) , the † PDBIDs are shown in italics throughout this manuscript mechanism of inhibition of CpLDH by gossypol is competitive with NADH (Fig. 2C) . The observed K i value for gossypol (11.6 µM) for CpLDH is in the same range but slightly higher than for the human enzyme (1.9 and 1.4 µM for M and H-forms, respectively; Gomez et al.,
1997).
In general, LDHs are inhibited by excess pyruvate, presumably due to the formation of an NAD + /pyruvate complex (Wang, 1977) . A distinctive biochemical feature of some protozoan LDHs is their insensitivity to high pyruvate concentration. As shown in Fig. 2D , CpLDH does not display any measurable inhibition to pyruvate concentrations up to at least 20 mM. (Davis et al., 2007) are listed in Table 3 .
General description and quality of the structures

Apo CpLDH
Apo CpLDH crystallizes in the space group P3 2 12, and the crystal structure contains two dimers (two half tetramers) in the asymmetric unit. The crystallographic symmetry pairs for each dimer form the functional tetramers. The model includes residues 17-98 and 112-330 for monomer A, 17-98 and 112-329 for monomer B, 18-98 and 112-329 for monomer C, and 18-98 and 112-327 for monomer D. The electron density for C-terminal residues and the active site loop (residues 99-111) was extremely weak, and those residues could not be modeled. The four CpLDH monomers in the asymmetric unit are nearly superimposable.
Compared to monomer A, the root mean square deviation for all Cα-atoms is 0.327 Å for B to A, 0.353 Å for C to A and 0.332 Å for D to A.
Ternary complexes of CpLDH
Crystals of the four ternary complexes belong to space group P3 2 21.The asymmetric unit contains two monomers related by non-crystallographic 2-fold symmetry (Fig. 3A) . The complete tetramer is formed with their symmetry partners related by a crystallographic 2-fold axis. In each complex the model includes residues 17-333 for each chain (see note at the end of the manuscript); only the last four C-terminal residues were not visible in the electrondensity maps. As shown in Supplementary Fig. S1 , in all four ternary complexes the NAD + /NADH site is fully occupied in both monomers in the asymmetric unit. Electron density for substrate molecules was also excellent in each subunit of all complexes except in the NADH/lactate complex, in which the density for lactate was clear only in subunit A. Average B-factors for the co-factor and substrate/analog molecules are comparable to those of the protein residues in each complex ( The overall quality of the structures of CpLDH is excellent. Only Ala164 and Gly283 in each monomer exhibit phi, psi angles in non-allowed regions of the Ramachandran plot. The residue corresponding to Ala164 is glycine in human and plasmodium LDH. All of the structures contain several glycerol molecules associated with each chain.
NADH/APADH and substrate binding sites
In the following description monomer A from the ternary complex CpLDH/NAD + /pyruvate (4ND4) will be used as the template unless otherwise stated.
CpLDH monomers are composed of two domains with the active site located at the interface of the two domains (Fig. 3A) . The NAD-binding domain (shown in light pink in Fig. 3A ) is characterized by a typical Rossmann fold consisting of a six-stranded parallel β-sheet flanked by α-helices. As shown in Fig. 3B and C, the adenine ring of the cofactor lies in a hydrophobic pocket formed by Ile27, Phe52, Ile54, Tyr85, Ala98, Ile119 and Val123 and packs against the side chains of Ile54 and Ala98. The hydroxyl oxygen atoms O2B and O3B of the adenosine ribose ring are hydrogen bonded to the side chain oxygen atoms of Asp53.
The diphosphate oxygen atoms are hydrogen bonded to water molecules and main chain N atoms of Gln31 and Ile32. The nicotinamide ring packs against the hydrophobic side chains of Ile32, Ile138 and Pro250 (Fig. 3B ). The hydroxyl oxygen atoms O2D and O3D of the nicotinamide-ribose are hydrogen bonded to the ND2 atom of Asn140 and the OG atom of Ser99, respectively (Fig. 3D ).
The conserved catalytic residues Arg171 and His195 (CpLDH numbering), which bind the substrate, are located in the catalytic domain (shown in magenta in Fig.3A ). The carboxyl oxygen atoms (O1 and O2) of pyruvate form hydrogen bonds with the side chain nitrogen atoms of Arg171, and O2 forms an additional contact with NH2 of Arg109. Atom O3 of pyruvate forms hydrogen bonds with atom NE2 of His195 and atom NE of Arg109 (Fig. 3D ).
Changes to apo-LDH on binding of substrate and cofactor
As expected, the overall structure of CpLDH is similar in the apo-form and various ternary complexes. Compared to monomer A in the CpLDH/NAD + /pyruvate structure, the r.m.s.d. deviation for all Cα-atoms is 0.883 Å. The major differences between the apo and complex structures are confined to five regions, and four of these regions are involved in binding the cofactor and the substrate. The most obvious difference is the absence of electron density for the active site loop (residues 99-111, Fig. 4A ), indicating disorder in the apo structure. The second region, residues 138-145, corresponds to the end of a short loop and the beginning of helix 4 (Fig. 4B ). This segment moves closer to the active site loop when the active site is occupied. The third region, residues 194-198, includes the conserved catalytic residue His195. The side chain of His195 assumes a different rotamer configuration in the apo structure (Fig. 4C ). This is different from the plasmodium and toxoplasma apo LDH structures, in which the side chain of the catalytic histidine residue has the same rotamer conformation as in substrate-bound LDH. The fourth region (residues 234-245) is at the end of a long helix (Fig. 4D ). This helix moves closer to the substrate in the CpLDH/NAD + /pyruvate structure. Finally, the long C-terminal helix moves closer to the adjacent beta sheet to form a slightly more compact structure overall (Fig. 4A ), but it does not seem to have any effect on the binding site.
Discussion
Comparison to human LDH
The crystal structures of human LDH have been determined in the apo form, as a binary complex with NADH (Dempster et al., 2014) and as ternary complexes (Read et al., 2001) .
The sequence identity between CpLDH and human LDH is 25%, and the r.m.s.d. value for the superposition of CpLDH (NAD + /oxamate complex) with the H form of human LDH bound to NADH and oxamate (PDBID: 1I0Z) is 1.050 Å. The overall architecture of CpLDH is similar to the structure of human LDH, and most of the structural differences are small and involve peripheral loops and the C-terminus (Fig. 5A) . However, there are two major differences. Conformation of the active site loop in CpLDH (residues 99-111) is considerably different from human LDH, even though it contains the same number of residues in both enzymes. Moreover, the helix-loop segment (residues 243-245) in the CpLDH structure also moves closer to the active site loop. A close-up view of the two above mentioned loops in the two structures is displayed in Fig. 5B . Electron density for the CpLDH residues in both loops was well defined (see Supplementary Fig. S2 ). The other major conformational difference between these structures is in the antigenic loop (CpLDH residues 210-225, 
Comparison to Plasmodium and Toxoplasma LDH
The crystal structures of LDH from T. gondii (TgLDH; Kavanagh et al., 2004) and three species of the malaria parasite have been determined: P. falciparum ((Dunn et al., 1996) , P.
vivax (Chaikuad et al., 2005) and P. berghei (Winter et al., 2003) . LDH structures from the three plasmodium species are almost identical, so only the P. falciparum LDH structure (PfLDH) will be used for comparison.
Results of primary sequence alignment using the CLUSTAL Omega server (http://www.ebi.ac.uk) (Goujon et al., 2010; Sievers et al., 2011) show that identity between (Figs. 1 and 6A,B) . The extra residues in the plasmodium and toxoplasma LDH structures cause the loop to protrude from the active site, while the absence of these extra residues in CpLDH results in a loop in which three residues (Ile100, Pro101
and Gly102) bulge out to form the surface of the binding site cavity ( et al., 2005) . PfLDH residues (Arg171, His195) that provide the major interactions with these inhibitors are identical in CpLDH. The other interacting residue, Pro246, is replaced by an alanine in CpLDH but in this case the main chain oxygen atom is involved in the interaction. Since these compounds are much smaller than gossypol additional protein-ligand interactions involving the remainder of gossypol structure are not known. However, these observations emphasize that in spite of the sequence similarity in the active site, subtle structural or conformational differences at or near the binding sites result in some degree of selectivity for a particular ligand.
Comparison to Malate Dehydrogenase (MDH)
LDH and MDH are homologous enzymes with a common protein fold and catalytic mechanism. Recently, evolutionary relationships among various clades of LDH/MDHs have been analyzed and discussed in detail (Boucher et al., 2014 . In Apicomplexa, evolution of the ldh gene resulted from a small number of mutations of a duplicated ancestral mdh gene (Zhu & Keithly, 2002; Boucher et al., 2014) . In these organisms LDH evolved independently twice, resulting in two lineages in Plasmodium-related species and in Cryptosporidium. In modern apicomplexan, LDH and MDH exhibit exquisite substrate specificity. The active site loop in these enzymes is highly significant not only in determining the rate of catalysis but also for substrate specificity (Bzik et al., 1993; Dunn et al., 1996; Waldman et al., 1988; Wilks et al., 1988) . In canonical LDHs residue 102 is glutamine, while the corresponding residue in all MDHs is arginine. A single mutation of this glutamine in canonical LDHs to arginine is sufficient to alter substrate specificity by three orders of magnitude (Wilks et al., 1988) . Thus residue 102 is termed the 'specificity residue.' Notably, the corresponding residue in apicomplexan LDH is Lys, and in the crystal structures of these LDHs this residue remains excluded from the active site. However, the most striking difference in the structures of these proteins is an insertion in the active site loop in LDH ( Figure 7B ). This insertion results in an alteration of the 'specificity residue' to Trp107 in modern apicomplexan LDHs which is lysine in all apicomplexan LDHs, is replaced by a glycine residue in CpLDH, and the five residue insertion seen in other apicomplexan LDHs is absent in CpLDH (Fig. 7B) .
APAD + versus NAD + binding
Structural details of the cofactor binding sites in apicomplexan LDHs provide insights for understanding the basis of their preference for APAD + over the natural substrate NAD + .
In mammalian LDHs, NAD + binding is favored by a hydrogen-bonding network formed by a serine residue (Ser161 in human), a highly conserved water molecule and the carboxyamide group (Fig. 8A) . When APAD + is substituted for NAD + , there is a loss of these two hydrogen bonds, resulting in a lower affinity for APAD + . However, in parasitic LDH structures only two hydrogen bonds are formed with NAD + (Fig. 8B ), resulting in a lower affinity for this cofactor than the human enzyme . Furthermore, replacement of the conserved serine residue by Met163 in CpLDH (leucine in plasmodium or methionine in toxoplasma) allows a better packing environment for the acetyl group of APAD + . Finally, there is a small rotation of the pyridine ring around the glycosidic bond connecting N1 and C1, which moves the methyl group away from the carbonyl oxygen atoms of Ile138 and Met163 (Fig. 9 ). For the LDH/APAD + /pyruvate structure this torsion angle is 132.2˚, while it ranges from 144.8˚ to 146.0˚ for the three complexes that bind NAD + /NADH. Although all of these changes are relatively small, together they are probably sufficient to explain the higher activity that
PfLDH and CpLDH show with APAD + compared to human LDH. As in the case of plasmodium, the elevated activity of CpLDH with APAD + may be useful as a diagnostic tool for detection of cryptosporidium.
Conclusions
Although the core of the CpLDH structure is similar to human LDH, it deviates in areas of functional significance. The differences in enzymatic characteristics of CpLDH and human LDH isoforms are explained by the differences in the amino acid sequences and threedimensional structures of these proteins. Many of the distinctive features of plasmodium and toxoplasma LDH are also conserved in the cryptosporidium enzyme. This suggests that active site inhibitors developed against enzymes of one parasite may be useful for designing broad-spectrum anti-parasitic agents.
Note
To preserve active-site nomenclature, LDHs are commonly numbered according to the initial assignment of residues from the X-ray structure of dogfish muscle LDH (Eventoff et al., 1977) . Since the primary sequence was not available at that time, errors were made that consequently required the elimination of some numbers and the insertion of others. Insertions relative to this reference have a letter appended to the residue number (i.e., 73B). CpLDH consists of 321 residues that are numbered from the initiator methionine at residue 17 to the C-terminal residue Ala337. Insertions occur at six places in the sequence, where amino acid designations have a letter appended to the number.
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Figure legends 1 Figure 1. Sequence alignment 2
Primary sequences of LDH from various organisms were aligned based on structural 3 homology. The labelling of secondary structural elements corresponds to the CpLDH 4 structure. The three black triangles indicate changes in the CpLDH sequence compared to 5 the GenBank sequence. This figure was prepared using ESPript (Gouet et al., 1999) . 6 Figure 2 . Enzymatic activity 7
A. CpLDH activity for reduction of pyruvate was measured using buffer solutions at 8 different pH. Relative activity is plotted against pH values. 9 B. CpLDH activity for oxidation of lactate was measured using buffer solutions at 10 different pH. Relative activity is plotted against pH values. 11 C. Ki values for gossypol were determined for reduction of pyruvate with NADH at pH 12 5.5. Pyruvate concentration was 5 mM, and NADH concentrations were varied 13 between 5-35 µM. Gossypol concentrations were 0, 2.5, 7.5 and 10 µM. 14 D. CpLDH activity was determined at saturating concentration of NADH (150 M) and 15 varying concentrations of pyruvate by measuring the decrease in absorbance at 340 nm. 16 Only the active site region is shown because the differences are restricted to this area. 21
Substrate binding residues of CpLDH and corresponding residues of CpMDH are 22
shown as stick models (carbon atoms are colored same as the respective protein chain Hs_H and Hs_M refer to the H and M isoforms. [Pyruvate], mM
